Evidence map›Paper›PMID 30455360›Full record

ArticleBlood advances2018

Intima-media thickness of the common femoral artery as a marker of leg ulceration in sickle cell disease patients.

Oluwagbemiga O Ayoola, Rahman A Bolarinwa, Uvie U Onakpoya, Tewogbade A Adedeji, Chidiogo C Onwuka, Bukunmi M Idowu

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Leg ulcers in sickle cell disease patients.Jornal vascular brasileiro · 2020
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Oluwagbemiga O AyoolaDepartment of Radiology, Faculty of Clinical Sciences, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.ORCID 0000-0002-7832-3390
Rahman A BolarinwaDepartment of Hematology and Immunology, Faculty of Basic Sciences.
Uvie U OnakpoyaDepartment of Surgery, Faculty of Clinical Sciences, and.
Tewogbade A AdedejiDeparment of Chemical Pathology, Faculty of Basic Sciences, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria; and.
Chidiogo C OnwukaDepartment of Radiology, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria.ORCID 0000-0002-5654-4002
Bukunmi M IdowuDepartment of Radiology, Union Diagnostics and Clinical Services Plc, Yaba, Lagos, Nigeria.ORCID 0000-0002-9811-5644
Obafemi Awolowo University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leg ulceration is a debilitating chronic complication of sickle cell disease (SCD) the pathogenesis of which is yet to be fully elucidated. We hypothesized that SCD patients with histories of previous leg ulcers would have intima hyperplasia of the common femoral artery (CFA). We enrolled 44 SCD patients and 33 age-matched and sex-matched controls with hemoglobin AA. Anthropometric measurements, biochemical parameters, and sonographic intima-media thickness (IMT) of the CFA were determined. The median CFA IMT in SCD limbs with history of leg ulcers (SWLU) was 1.0 mm, whereas it was 0.7 mm in SCD limbs with no history of leg ulcer (SNLU) and 0.60 mm in controls (

Indexed as

AdultAnemia, Sickle CellBiomarkersBody Mass IndexCarotid Intima-Media ThicknessCase-Control StudiesCross-Sectional StudiesFemaleFemoral ArteryHumansLeg UlcerLogistic ModelsMaleOdds RatioRisk FactorsYoung AdultBiomarkers

Identifiers

PMID30455360
PMCPMC6258917
OpenAlexW2901301403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.